查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1554195

2 型糖尿病治療市場規模、佔有率、趨勢分析報告：按藥物類別、給藥途徑、分銷管道、地區、細分市場預測，2024-2030 年

Type 2 Diabetes Mellitus Treatment Market Size, Share & Trends Analysis Report By Drug Class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 95 Pages | 商品交期: 2-10個工作天內

價格

2 型糖尿病治療市場成長與趨勢：

Grand View Research, Inc.的研究報告顯示，預計到2030年，全球2型糖尿病治療市場規模將達到919億美元，2024年至2030年複合年成長率為6.9%。

這種擴張是由日益增加的全球 2 型糖尿病負擔和治療方案的進步所推動的。由於不良飲食習慣和缺乏運動等生活方式的改變導致肥胖率增加，2 型糖尿病的發生率正在上升。根據國際糖尿病聯盟（IDF）統計，全球有超過 5 億人患有糖尿病，其中約 90% 患有第 2 型糖尿病。患者數量的不斷增加刺激了對有效和創新治療的需求。

糖尿病管理的進步正在推動市場成長。 GLP-1 受體促效劑和 SGLT2 抑制劑等新型治療藥物的開發顯著改善了治療效果。這些藥物不僅可以降低血糖值，還可以提供其他益處，例如心血管保護和體重管理。新的胰島素配方和技術（例如連續血糖監測儀和胰島素幫浦）的引入正在進一步改善患者照護並推動市場擴張。例如，2023年1月，食品藥物管理局（FDA）核准諾和諾德的糖尿病治療藥物Libersus作為降低血糖值的第一線藥物。這項核准使 2 型糖尿病患者能夠與他們的醫療保健提供者合作，將 Libersus 納入他們的治療計劃中，為他們提供從症狀出現時就控制病情的新選擇。

此外，增加醫療保健投資和改善糖尿病治療的機會也有助於市場成長。政府和醫療保健組織正在投資糖尿病管理計劃、公眾意識提升宣傳活動和醫療保健基礎設施。這些努力旨在加強早期診斷、治療順從性和整體患者管理。

2 型糖尿病治療市場報告亮點

  • 2023年，胰島素製劑在第2型糖尿病治療市場中佔最大銷售佔有率，達32.8%。這一成長主要是由於久坐的生活方式導致全球 2 型糖尿病盛行率不斷增加。
  • 預計在預測期內，皮下注射將在第 2 型糖尿病治療市場中實現最高的複合年成長率 (9.4%)。
  • 2023年，零售藥局業務在第2型糖尿病治療市場中佔最大銷售佔有率，約70.0%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 2 型糖尿病治療市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 2型糖尿病治療市場、市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章 2 型糖尿病治療市場：依藥物類別估算與趨勢分析

  • 全球第 2 型糖尿病治療市場：藥物類別儀表板
  • 全球第2型糖尿病治療市場：藥物類別波動分析
  • 全球 2 型糖尿病治療市場：按藥物類別分類的收益
  • 胰島素
  • DPP-4抑制劑
  • GLP-1受體促效劑
  • SGLT2抑制劑
  • 其他

第5章 2型糖尿病治療市場：依給藥途徑估計與趨勢分析

  • 全球第 2 型糖尿病治療市場：途徑儀表板
  • 全球第2型糖尿病治療市場：給藥途徑變化分析
  • 按途徑的收益
  • 口服
  • 皮下的
  • 靜脈

第6章 2型糖尿病治療市場：依通路估算與趨勢分析

  • 全球 2 型糖尿病治療市場：分銷通路儀表板
  • 全球第2型糖尿病治療市場：通路波動分析
  • 按分銷管道分類的收益
  • 零售藥房
  • 醫院藥房
  • 其他

第7章 2型糖尿病治療市場：按藥物類別、給藥途徑和分銷管道分類的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭格局

  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 2023年主要企業市場佔有率分析
    • AstraZeneca PLC
    • Boehringer Ingelheim International GmbH
    • Eli Lilly and Co.
    • Merck &Co. Inc
    • Novartis AG
    • Novo Nordisk AS
    • Sanofi SA
    • Takeda Pharmaceutical Co. Ltd
Product Code: GVR-4-68040-430-4

Type 2 Diabetes Mellitus Treatment Market Growth & Trends:

The global type 2 diabetes mellitus treatment market size is anticipated to reach USD 91.9 billion by 2030, growing at a CAGR of 6.9% from 2024 to 2030, according to a report by Grand View Research, Inc. This expansion is driven by the increasing global burden of type 2 diabetes and advancements in treatment options. As lifestyle changes, such as poor dietary habits and physical inactivity, contribute to higher obesity rates, the incidence of type 2 diabetes is on the rise. According to the International Diabetes Federation (IDF), over 500 million people worldwide are affected by diabetes, with Type 2 diabetes accounting for approximately 90% of these cases. This growing patient population fuels demand for effective and innovative treatments.

Advancements in diabetes management are boosting market growth. The development of new classes of medications, such as GLP-1 receptor agonists and SGLT2 inhibitors, has significantly improved treatment outcomes. These therapies not only lower blood glucose levels but also offer additional benefits like cardiovascular protection and weight management. The introduction of novel insulin formulations and technologies, including continuous glucose monitors and insulin pumps, further enhances patient care and drives market expansion. For instance, in January 2023, the Food and Drug Administration (FDA) approved Novo Nordisk's diabetes medication, Rybelsus, as a first-line treatment for lowering blood sugar levels. With this approval, individuals with Type 2 diabetes, in collaboration with their healthcare providers, can now incorporate Rybelsus early in their treatment plan, offering a new option for managing their condition from the onset.

In addition, increasing healthcare investments and improved access to diabetes care contribute to market growth. Governments and healthcare organizations are investing in diabetes management programs, public awareness campaigns, and healthcare infrastructure improvements. These efforts aim to enhance early diagnosis, treatment adherence, and overall patient management.

Type 2 Diabetes Mellitus Treatment Market Report Highlights:

  • In 2023, the insulin segment accounted for the largest revenue share of 32.8% in diabetes mellitus, type 2 treatment market. This growth primarily is attributed to the rising prevalence of type 2 diabetes around the world due to sedentary lifestyle
  • Subcutaneous are anticipated to achieve the highest CAGR of 9.4% in the diabetes mellitus, type 2 treatment market during the forecast period
  • The retail pharmacies segment accounted for the largest revenue share of around 70.0% in diabetes mellitus, type 2 treatment market in 2023

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Route of Administration
    • 1.2.3. Distribution Channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Drug Class Outlook
    • 2.2.2. Route of Administration
    • 2.2.3. Distribution Channel
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Type 2 Diabetes Mellitus Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Prevalence of Diabetes
      • 3.2.1.2. Advancements In Treatment Options
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Treatment Cost
      • 3.2.2.2. Patient Non-Adherence
  • 3.3. Type 2 Diabetes Mellitus Treatment Market, Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Type 2 Diabetes Mellitus Treatment Market: Drug Class Estimates & Trend Analysis

  • 4.1. Global Type 2 Diabetes Mellitus Treatment Market: Drug Class Dashboard
  • 4.2. Global Type 2 Diabetes Mellitus Treatment Market: Drug Class Movement Analysis
  • 4.3. Global Type 2 Diabetes Mellitus Treatment Market by Drug Class, Revenue
  • 4.4. Insulin
    • 4.4.1. Insulin market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. DPP-4 Inhibitors
    • 4.5.1. DPP-4 Inhibitors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. GLP-1 Receptor Agonists
    • 4.6.1. GLP-1 Receptor Agonists market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. SGLT2 Inhibitors
    • 4.7.1. SGLT2 Inhibitors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Type 2 Diabetes Mellitus Treatment Market: Route of Administration Estimates & Trend Analysis

  • 5.1. Global Type 2 Diabetes Mellitus Treatment Market: Route of Administration Dashboard
  • 5.2. Global Type 2 Diabetes Mellitus Treatment Market: Route of Administration Movement Analysis
  • 5.3. Global Type 2 Diabetes Mellitus Treatment Market Estimates and Forecasts, By Route of Administration, Revenue (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Subcutaneous
    • 5.5.1. Subcutaneous market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Intravenous
    • 5.6.1. Intravenous market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Global Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Dashboard
  • 6.2. Global Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Movement Analysis
  • 6.3. Global Type 2 Diabetes Mellitus Treatment Market Estimates and Forecasts, By Distribution Channel, Revenue (USD Million)
  • 6.4. Retail Pharmacies
    • 6.4.1. Retail Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Hospital Pharmacies
    • 6.5.1. Hospital Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Other
    • 6.6.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Type 2 Diabetes Mellitus Treatment Market: Regional Estimates & Trend Analysis by Drug Class, Route of Administration, and Distribution Channel

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Vendor Landscape
    • 8.2.1. List of key distributors and channel partners
    • 8.2.2. Key company market share analysis, 2023
    • 8.2.3. AstraZeneca PLC
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Boehringer Ingelheim International GmbH
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Eli Lilly and Co.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Merck & Co. Inc
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Novartis AG
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Novo Nordisk AS
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Sanofi SA
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Takeda Pharmaceutical Co. Ltd
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List Of Abbreviation
  • Table 2 North America Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 4 North America Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 5 North America Type 2 Diabetes Mellitus Treatment Market, Distribution Channel, 2018 - 2030 (USD Million)
  • Table 6 U.S. Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 7 U.S. Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 8 U.S. Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9 Canada Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 10 Canada Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 11 Canada Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 12 Mexico Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 13 Mexico Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 14 Mexico Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15 Europe Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 16 Europe Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 17 Europe Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 18 Europe Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Germany Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 20 Germany Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 21 Germany Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22 UK Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 23 UK Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 UK Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25 France Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 26 France Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 27 France Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28 Italy Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 29 Italy Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 30 Italy Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 31 Spain Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 32 Spain Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 33 Spain Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 Denmark Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 35 Denmark Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 36 Denmark Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 Sweden Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 38 Sweden Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 39 Sweden Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40 Norway Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 41 Norway Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 42 Norway Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 China Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 48 China Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 49 China Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Japan Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 51 Japan Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 52 Japan Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 India Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 54 India Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 55 India Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56 South Korea Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 57 South Korea Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 58 South Korea Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59 Australia Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 60 Australia Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 Australia Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Thailand Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 63 Thailand Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 64 Thailand Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65 Latin America Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 66 Latin America Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 67 Latin America Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 68 Latin America Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Brazil Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 70 Brazil Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 71 Brazil Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 72 Argentina Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 73 Argentina Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Argentina Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 MEA Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 76 MEA Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 77 MEA Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 78 MEA Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 South Africa Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 80 South Africa Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 81 South Africa Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 85 UAE Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 86 UAE Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 87 UAE Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Type 2 Diabetes Mellitus Treatment Market, Market: Market Outlook
  • Fig. 14 Type 2 Diabetes Mellitus Treatment Market, Competitive Insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Type 2 diabetes mellitus treatment Market Driver Impact
  • Fig. 18 Type 2 Diabetes Mellitus Treatment Market Restraint Impact
  • Fig. 19 Type 2 Diabetes Mellitus Treatment Market Strategic Initiatives Analysis
  • Fig. 20 Type 2 Diabetes Mellitus Treatment Market: Drug Class Movement Analysis
  • Fig. 21 Type 2 Diabetes Mellitus Treatment Market: Drug Class Outlook And Key Takeaways
  • Fig. 22 Insulin market estimates and forecast, 2018 - 2030
  • Fig. 23 DPP-4 inhibitors market estimates and forecast, 2018 - 2030
  • Fig. 24 GLP-1 receptor agonists market estimates and forecast, 2018 - 2030
  • Fig. 25 SGLT2 inhibitors market estimates and forecast, 2018 - 2030
  • Fig. 26 Other market estimates and forecast, 2018 - 2030
  • Fig. 27 Type 2 Diabetes Mellitus Treatment Market: Route of Administration Movement Analysis
  • Fig. 28 Type 2 Diabetes Mellitus Treatment Market: Route of Administration Outlook And Key Takeaways
  • Fig. 29 Oral market estimates and forecast, 2018 - 2030
  • Fig. 30 Subcutaneous market estimates and forecast, 2018 - 2030
  • Fig. 31 Intravenous market estimates and forecast, 2018 - 2030
  • Fig. 32 Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Movement Analysis
  • Fig. 33 Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Outlook And Key Takeaways
  • Fig. 34 Retail pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 35 Hospital pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 36 Other market estimates and forecast, 2018 - 2030
  • Fig. 37 Global Type 2 Diabetes Mellitus Treatment Market: Regional Movement Analysis
  • Fig. 38 Global Type 2 Diabetes Mellitus Treatment Market: Regional Outlook And Key Takeaways
  • Fig. 39 Global Type 2 Diabetes Mellitus Treatment market share and leading players
  • Fig. 40 North America, by country
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. key country dynamics
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Canada key country dynamics
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico key country dynamics
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 UK key country dynamics
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Germany key country dynamics
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 France key country dynamics
  • Fig. 54 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Italy key country dynamics
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Spain key country dynamics
  • Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Denmark key country dynamics
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Sweden key country dynamics
  • Fig. 62 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Norway key country dynamics
  • Fig. 64 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 China key country dynamics
  • Fig. 67 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Japan key country dynamics
  • Fig. 69 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 India key country dynamics
  • Fig. 71 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Thailand key country dynamics
  • Fig. 73 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 South Korea key country dynamics
  • Fig. 75 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Australia key country dynamics
  • Fig. 77 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Brazil key country dynamics
  • Fig. 80 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Argentina key country dynamics
  • Fig. 82 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 South Africa key country dynamics
  • Fig. 85 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Saudi Arabia key country dynamics
  • Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 UAE key country dynamics
  • Fig. 89 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Kuwait key country dynamics
  • Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Market share of key market players- Type 2 Diabetes Mellitus Treatment market